Sabra Health Care REIT, Inc. is classed by the SEC under Real Estate Investment Trusts (industry code 6798), based in Tustin, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $357 million and a profit of $156 million (its filed statements).
Property businessReal Estate Investment TrustsTustin, CAfilings since 20109 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a property business: prior from its industry code (SEC 6798, Real Estate Investment Trusts); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 6.1 out of ten, 9 of 9 metrics filed: past 6.2 out of ten, present 5.5 out of ten, future 6.7 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 7.0 out of ten. No warning events in its filings since 2017. 70th percentile among 174 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 5.4 out of ten. +12.9% a year over 10 filed years; profitable in 8 of 10. 54th percentile among 156 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 5.9 out of ten. Share count grew 1.9% a year. 88% of cash flow returned. Insiders: 2 sales, 0 purchases. 59th percentile among 156 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 5.1 out of ten. ROE 6%: 6¢ of profit per shareholder dollar. Leverage 49%: owes 49¢ per asset dollar. 51st percentile among 171 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 5.8 out of ten. top 42% of 157 in its family; net margin 20.1%. 58th percentile among 157 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 6.1 out of ten. top 39% of 161 in its family for leadership; chief executive since 2010. 61st percentile among 161 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 4.8 out of ten. bottom 48% of 146 in its family for room to expand. 48th percentile among 146 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 5.4 out of ten. top 46% of 153 in its family for growth drivers. 54th percentile among 153 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 8.5 out of ten. top 15% of 150 in its family for expectations against reality. 85th percentile among 150 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-12 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-03 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-03 (on EDGAR). Newest filing: Form 4, 2026-09-09. Filings on record since 2010. Read from EDGAR 2026-10-12.
Who runs it
Matros, Richard K (Chair, CEO and President); Costa, Michael Lourenco (Executive VP, CFO & Treasurer); Flores, Jessica (Executive VP & CAO); Smith, Darrin (Executive VP, CIO & Secretary); Nevo-Hacohen, Talya (Executive VP, CIO & Treasurer); Barbarosh, Craig A. (director); Cusack, Catherine (director); Foster, Michael J (director); Katzmann, Lynne S (director); Kono, Ann (director); and 1 more. 11 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.